Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Minnelide

Home DrugsMinnelide

Investigational

Small Molecule

Minnelide

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₂₁H₂₅Na₂O₁₀P
CAS Number: 1254702-87-8
UNII ID: 1CIV2UMO40

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

DRUG COMBINATION FOR THE TREATMENT OF STOMACH CANCER
EP 4447956 C0Applicant: MINNEAMRITA THERAPEUTICS LLCPriority: 2023
EP
US
WO
6 publications
DRUG COMBINATION FOR TREATMENT OF PANCREATIC CANCER
EP 4676463 A1Applicant: MINNEAMRITA THERAPEUTICS LLCPriority: 2023
EP
US
WO
3 publications
一类雷公藤甲素前药、其制备方法及其医药用途
CN 114478684 BApplicant: 南京中医药大学Priority: 2022
CN